Join the National Institutes of Health’s National Institute on Aging (NIA) Office of Small Business Research (OSBR) and National Heart, Lung, and Blood Institute (NHLBI) Office of Translational Alliances and Coordination (OTAC), in collaboration with the University of Kentucky Office of Technology Commercialization, on Tuesday, February 23, 2021, at noon ET for a webinar on small business funding opportunities to advance your research to the commercialization stage. Armineh Ghazarian, M.S.F., OSBR Program Analyst, will provide an overview of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, guidance on drafting a competitive application, and additional resources to help you advance your research. Stephanie M. Davis, Ph.D., OTAC Small Business Program Coordinator, will provide an overview of NHLBI research priorities and highlight some of the resources available for heart, lung, and blood-related innovations.
The NIA Office of Small Business Research (OSBR) manages the largest source of early-stage funding for aging-related research and development (R&D).
The NHLBI Office of Translational Alliances and Coordination (OTAC) helps to accelerate the translation of new discoveries into innovative biomedical products to prevent, diagnose, and treat heart, lung, and blood disorders. OTAC coordinates the NHLBI Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, as well as two translational research initiatives directed at advancing new technologies from the university to the marketplace: the NIH Centers for Accelerated Innovations (NCAI) and the NIH Research Evaluation and Commercialization Hubs (REACH) programs.
In addition, OTAC serves as a central point-of-contact for information about the NHLBI’s small business funding opportunities; facilitates alliances between the federal and private sector stakeholders; and offers resources and advisory services to support biomedical innovators.
The University of Kentucky Office of Technology Commercialization (OTC) mission is to advance innovation that makes a difference.
Do you have a great company in the bioscience or medtech industry? Do you need wet-lab and/or fabrication space to develop and test your product?
